
Kvantify is a life sciences company focused on solving complex computational challenges, particularly in drug discovery, by leveraging quantum physics-based software and High-Performance Computing (HPC). Their mission is to democratize access to advanced computing technologies, making them available to businesses without requiring large in-house investments or expert knowledge. Kvantify develops pioneering solutions and offers collaborative services that improve the quality of compounds tested in labs, optimize drug discovery pipelines, and accelerate the design-make-test-analyze cycle. Their approach integrates classical and quantum computing, delivering immediate value through optimized classical methods while preparing for future quantum advancements. Their primary product, Koffee, is a platform for binding affinity & kinetics calculations designed to help pharma and biotech companies iterate smarter, save time and money, and de-risk their drug discovery processes.

Kvantify is a life sciences company focused on solving complex computational challenges, particularly in drug discovery, by leveraging quantum physics-based software and High-Performance Computing (HPC). Their mission is to democratize access to advanced computing technologies, making them available to businesses without requiring large in-house investments or expert knowledge. Kvantify develops pioneering solutions and offers collaborative services that improve the quality of compounds tested in labs, optimize drug discovery pipelines, and accelerate the design-make-test-analyze cycle. Their approach integrates classical and quantum computing, delivering immediate value through optimized classical methods while preparing for future quantum advancements. Their primary product, Koffee, is a platform for binding affinity & kinetics calculations designed to help pharma and biotech companies iterate smarter, save time and money, and de-risk their drug discovery processes.
Headquarters: Copenhagen, Denmark
Founded: 2022
Sector: Quantum computing & HPC for life sciences
Flagship product: Koffee (binding affinity & kinetics platform)
Notable investors: Lundbeckfonden Ventures, Nordic Makers, QAI Ventures, Dreamcraft Ventures, 2degrees
25,121,700 USD
Computational challenges in drug discovery (binding affinity & kinetics), and broader hard problems in life sciences, finance and logistics.
2022
Biotechnology
Seed round recorded with investors including 2degrees, Dreamcraft Ventures, Lundbeckfonden Ventures
Later venture round recorded with multiple Nordic investors including QAI Ventures, Nordic Makers, Lundbeckfonden Ventures, Export and Investment Fund, Dreamcraft Ventures
“Syndicate of Nordic and specialist deep-tech investors (examples: Lundbeckfonden Ventures, Nordic Makers, QAI Ventures, Dreamcraft Ventures, 2degrees)”